Arvest Bank Trust Division’s Eli Lilly LLY Stock Holding History

Arvest Bank Trust Division’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.56M	Sell	9,309 -140	-1%	-$142K	0.47%	47
2025 Q4	$10.2M	Buy	9,449 +438	+5%	+$419K	0.55%	50
2025 Q3	$6.88M	Buy	9,011 +8,366	+1,297%	+$6.23M	0.38%	62
2025 Q2	$503K	Sell	645 -15	-2%	-$11.7K	0.03%	141
2025 Q1	$545K	Buy	660 +185	+39%	+$154K	0.03%	127
2024 Q4	$367K	Sell	475 -54	-10%	-$44.7K	0.02%	141
2024 Q3	$469K	Buy	+529	New	+$476K	0.03%	126
2021 Q3	$451K	Buy	1,952 +114	+6%	+$28.1K	0.03%	121
2021 Q2	$422K	Buy	1,838 +26	+1%	+$5.22K	0.02%	119
2021 Q1	$339K	Sell	1,812 -2,846	-61%	-$557K	0.02%	120
2020 Q4	$786K	Buy	4,658 +965	+26%	+$144K	0.05%	74
2020 Q3	$547K	Buy	3,693 +1,910	+107%	+$296K	0.04%	79
2020 Q2	$293K	Buy	1,783 +161	+10%	+$24.7K	0.02%	96
2020 Q1	$225K	Buy	+1,622	New	+$223K	0.02%	106
2016 Q3	–	Sell	-3,292	Closed	-$259K	–	135
2016 Q2	$259K	Buy	+3,292	New	+$248K	0.02%	108

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arvest Bank Trust Division's LLY Position: Q1 2026 in Review

Arvest Bank Trust Division reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $142K and leaving 9,309 shares worth $8.56M. The position accounts for 0.47% of the portfolio, ranked #47.

Arvest Bank Trust Division first reported a position in LLY in Q2 2016 and has held it in 15 quarters since. The position peaked at $10.2M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Arvest Bank Trust Division held 9,309 shares of Eli Lilly worth $8.56M as of Q1 2026.
Arvest Bank Trust Division sold 140 Eli Lilly shares in Q1 2026, an estimated $142K.
Eli Lilly made up 0.47% of Arvest Bank Trust Division's portfolio in Q1 2026, its #47 holding.
Arvest Bank Trust Division first reported a position in Eli Lilly in Q2 2016 and has held it in 15 quarters since.
Arvest Bank Trust Division's Eli Lilly position peaked at $10.2M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Arvest Bank Trust Division's 13F filing for Q1 2026, filed 13 May 2026.